Plant Sterols Fail to Lower LDL in a Small Trial of Adults With Obesity
A small randomized trial found 2 grams of plant sterols daily did not improve LDL cholesterol or other metabolic measures versus placebo.
Summary
Plant sterol supplements may not reliably lower cholesterol in adults with obesity, according to a small randomized trial. Researchers studied 23 adults with overweight or obesity and mildly elevated cholesterol. Each participant took 2 grams of plant sterols daily and a placebo during separate eight-week periods, with a six-week break between them. LDL cholesterol did not differ significantly between treatments. Neither did other blood fats, inflammation, or blood sugar measures. Differences in body composition, muscle health, and lifestyle measures were not significant after accounting for multiple comparisons. The findings suggest that supplement users should check their cholesterol response rather than assume a benefit. However, this small, short study cannot rule out modest effects or establish that plant sterols never help this population. This summary is based on the abstract only.
Detailed Summary
Plant sterol supplements are often used to lower LDL cholesterol, a contributor to cardiovascular disease. Whether they work equally well in adults with obesity matters because this group already faces elevated metabolic and heart risks. A small randomized trial found no detectable benefit from a commonly used daily dose, challenging assumptions that these supplements reliably improve cholesterol across different populations.
Researchers enrolled 23 participants with overweight or obesity and mildly elevated cholesterol. Their average body mass index was 36.4. In a randomized, double-blind crossover design, each participant received both treatments in separate phases: 2 grams of plant sterols daily and a placebo. Each phase lasted eight weeks, separated by six weeks without treatment. LDL cholesterol was the primary measured outcome.
Plant sterols did not lower LDL cholesterol compared with placebo. Average changes from baseline were an increase of 0.1 milligrams per deciliter with sterols and 3.9 with placebo; the comparison was not statistically significant. Other cholesterol measures, an inflammation marker, and measures of blood sugar regulation also showed no differences between treatments. These findings do not establish equivalence between treatments.
Body composition, muscle health, and lifestyle outcomes likewise showed no significant differences after statistical adjustment for testing multiple outcomes. For adults with obesity considering plant sterols, the practical message is to verify cholesterol response with blood tests rather than assume benefit. Supplements should not replace established cardiovascular risk management, and these results do not demonstrate weight loss or improved longevity.
Important uncertainties remain. Only 23 participants were studied, treatment periods were short, and the trial was powered specifically for LDL cholesterol, not secondary outcomes. Small benefits or subgroup differences could have been missed. The abstract does not provide detailed safety findings or participant ages. This summary relies on the abstract only; larger studies are needed before drawing broad clinical conclusions.
Key Findings
- Two grams of plant sterols daily for eight weeks did not significantly lower LDL cholesterol versus placebo in 23 participants.
- LDL changed by +0.1 mg/dL with sterols versus +3.9 mg/dL with placebo; the between-treatment comparison was not significant (p = 0.632).
- Other lipid measures, inflammation, and blood sugar regulation showed no significant differences between treatments.
- Body composition, muscle health, and lifestyle differences did not remain significant after correction for multiple testing.
- Check cholesterol response rather than assuming supplementation helps; this small trial cannot exclude modest benefits.
Methodology
This randomized, double-blind, placebo-controlled crossover trial enrolled 23 participants with overweight or class I–III obesity and mild hypercholesterolemia. Participants received 2 g/day of plant sterols and placebo for eight weeks each, separated by a six-week washout; LDL cholesterol was the primary outcome. The trial was registered as NCT06481020.
Study Limitations
This summary is based on the abstract only, which does not provide detailed safety, adherence, or participant age information. The sample was small and treatment periods were short, limiting conclusions about modest effects, long-term outcomes, and broader populations. Only LDL cholesterol was adequately powered as a primary outcome; secondary findings are exploratory.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: